WallStreetZenWallStreetZen

NASDAQ: BIMI
Bimi International Medical Inc Earnings & Revenue

OverviewEarnings
DividendOwnership

BIMI past revenue growth

How has BIMI's revenue growth performed historically?
Company
-54.23%
Industry
1.65%
Market
13.73%
BIMI's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
BIMI's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
BIMI's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

BIMI earnings and revenue history

Current Revenue
$10.0M
Current Earnings
-$20.5M
Current Profit Margin
-205.2%

BIMI Return on Equity

Current Company
-230.7%
Current Industry
-13.5%
Current Market
27.8%
BIMI's Return on Equity (-230.7%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when BIMI announces earnings.

BIMI Return on Assets

Current Company
-56.6%
Current Industry
-3.6%
BIMI is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

BIMI Return on Capital Employed

Current Company
-149.7%
Current Industry
-7.4%
BIMI's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

BIMI vs Pharmaceutical Retailer Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
BIMI$10.01M-$20.27M-$20.54M+5.61%N/A
SSY$46.84M-$1.14M-$2.73M-1.55%N/A
CJJD$148.81M-$19.96M-$21.14M+9.14%N/A
MEDS$9.43M-$3.32M-$4.08M+24.00%N/A
MDVL$23.84M-$40.84M-$46.00M+120.05%N/A
View Top Pharmaceutical Retailer Stocks

BIMI earnings dates

Next earnings date
Nov 20, 2023

Bimi International Medical Earnings & Revenue FAQ

What were BIMI's earnings last quarter?

On Invalid Date, Bimi International Medical (NASDAQ: BIMI) reported Q1 2023 earnings per share (EPS) of -$0.23, up 92.07% year over year. Total Bimi International Medical earnings for the quarter were -$884.21 thousand. In the same quarter last year, Bimi International Medical's earnings per share (EPS) was -$2.90.

If you're new to stock investing, here's how to buy Bimi International Medical stock.

What was BIMI's earnings growth in the past year?

As of Q3 2023, Bimi International Medical's earnings has grown year over year. Bimi International Medical's earnings in the past year totalled -$20.54 million.

What is BIMI's earnings date?

Bimi International Medical's earnings date is Invalid Date. Add BIMI to your watchlist to be reminded of BIMI's next earnings announcement.

What was BIMI's revenue last quarter?

On Invalid Date, Bimi International Medical (NASDAQ: BIMI) reported Q1 2023 revenue of $3.20 million up 17.79% year over year. In the same quarter last year, Bimi International Medical's revenue was $2.71 million.

What was BIMI's revenue growth in the past year?

As of Q3 2023, Bimi International Medical's revenue has grown -54.23% year over year. This is 55.88 percentage points lower than the US Pharmaceutical Retailers industry revenue growth rate of 1.65%. Bimi International Medical's revenue in the past year totalled $10.01 million.
©2023 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.